Diagnostic performance of thromboelastography and systemic inflammatory indicators in chronic glomerulonephritis: a

Mengyuan Ding1, Xuelian Huang2, Qi Xiao1

  • 1Blood Group Reference Laboratory, Suzhou Blood Center, Suzhou, Jiangsu, China.

PubMed

Insights

Thromboelastography (TEG) and systemic inflammatory markers show significant associations with chronic glomerulonephritis (CGN). These indicators, including Angle, MA, WBC, and SIRI, can serve as valuable biomarkers for CGN diagnosis.

Area of Science:

  • Nephrology and Hematology
  • Diagnostic Biomarkers
  • Inflammation and Coagulation

Background:

  • Chronic glomerulonephritis (CGN) diagnosis relies on invasive methods.
  • There is a need for non-invasive, effective auxiliary diagnostic tools for CGN.
  • Thromboelastography (TEG) and systemic inflammation indicators have potential as diagnostic aids.

Purpose of the Study:

  • To evaluate TEG parameters and systemic inflammatory indicators as auxiliary diagnostic tools for CGN.
  • To assess the clinical applicability and effectiveness of these combined markers.
  • To establish reference data for future biomarker studies in CGN.

Main Methods:

  • A case-control study involving 419 CGN patients and 419 healthy controls.
  • TEG was used to measure coagulation function; automated analyzers measured blood indices.
  • Systemic inflammation index was calculated, and associations were analyzed.

Main Results:

  • CGN patients showed significantly elevated inflammatory markers (SIRI, SII, NLR, WBC) and altered coagulation parameters (increased Angle, MA; decreased K, LY30) compared to controls.
  • Age, Angle, MA, LY30, WBC, and SIRI were identified as independent risk factors for CGN.
  • Combining age, TEG, and inflammatory indicators achieved an AUC of 0.782 for CGN diagnosis.

Conclusions:

  • TEG parameters and inflammatory indicators are significantly associated with CGN.
  • These markers demonstrate potential as clinically applicable auxiliary diagnostic tools for CGN.
  • The reported data and thresholds can guide future research on CGN biomarkers.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
387
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
776
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
529